Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek A Wainwright

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Experimental and Molecular Pathology|May 14, 2011
The expression of BST2 in human and experimental mouse brain tumorsDerek A Wainwright, Irina V Balyasnikova, Yu Han, et al.
Current Opinion in Immunology|April 4, 2021
Tryptophan metabolism in brain tumors - IDO and beyondMichael Platten, Mirco Friedrich, Derek A Wainwright, et al.
Expert Opinion on Emerging Drugs|April 27, 2012
Recent developments on immunotherapy for brain cancerDerek A Wainwright, Pragati Nigam, Bart Thaci, et al.
Current Opinion in Pharmacology|August 11, 2020
Targeting CD73 to augment cancer immunotherapyMeejeon Roh, Derek A Wainwright, Jennifer D Wu, et al.
Plos One|November 10, 2010
The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human gliomaDerek A Wainwright, Sadhak Sengupta, Yu Han, et al.
Journal of Neurodegeneration & Regeneration|May 4, 2010
Effects of facial nerve axotomy on Th2-associated and Th1-associated chemokine mRNA expression in the facial motor nucleus of wild-type and presymptomatic SOD1 miceDerek A Wainwright, Nichole A Mesnard, Junping Xin, et al.
Neuroscience Letters|January 9, 2010
Toll-like receptor 2 and facial motoneuron survival after facial nerve axotomyDerek A Wainwright, Junping Xin, Nichole A Mesnard, et al.
Brain, Behavior, and Immunity|November 21, 2007
Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomyJunping Xin, Derek A Wainwright, Craig J Serpe, et al.
Drugs|October 11, 2019
Immunotherapy Against Gliomas: is the Breakthrough Near?Rimas V Lukas, Derek A Wainwright, Craig M Horbinski, et al.
Oncology (Williston Park, N.Y.)|March 14, 2019
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementRimas V Lukas, Derek A Wainwright, Erik Ladomersky, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Experimental and Molecular Pathology|May 14, 2011
The expression of BST2 in human and experimental mouse brain tumorsDerek A Wainwright, Irina V Balyasnikova, Yu Han, et al.
Current Opinion in Immunology|April 4, 2021
Tryptophan metabolism in brain tumors - IDO and beyondMichael Platten, Mirco Friedrich, Derek A Wainwright, et al.
Expert Opinion on Emerging Drugs|April 27, 2012
Recent developments on immunotherapy for brain cancerDerek A Wainwright, Pragati Nigam, Bart Thaci, et al.
Current Opinion in Pharmacology|August 11, 2020
Targeting CD73 to augment cancer immunotherapyMeejeon Roh, Derek A Wainwright, Jennifer D Wu, et al.
Plos One|November 10, 2010
The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human gliomaDerek A Wainwright, Sadhak Sengupta, Yu Han, et al.
Journal of Neurodegeneration & Regeneration|May 4, 2010
Effects of facial nerve axotomy on Th2-associated and Th1-associated chemokine mRNA expression in the facial motor nucleus of wild-type and presymptomatic SOD1 miceDerek A Wainwright, Nichole A Mesnard, Junping Xin, et al.
Neuroscience Letters|January 9, 2010
Toll-like receptor 2 and facial motoneuron survival after facial nerve axotomyDerek A Wainwright, Junping Xin, Nichole A Mesnard, et al.
Brain, Behavior, and Immunity|November 21, 2007
Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomyJunping Xin, Derek A Wainwright, Craig J Serpe, et al.
Drugs|October 11, 2019
Immunotherapy Against Gliomas: is the Breakthrough Near?Rimas V Lukas, Derek A Wainwright, Craig M Horbinski, et al.
Oncology (Williston Park, N.Y.)|March 14, 2019
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementRimas V Lukas, Derek A Wainwright, Erik Ladomersky, et al.
Pageof 9